This conference covered the whole area of DNA vaccine design starting from gene design, defining of transcription and translation signals, packaging, delivery, induction of innate immune response and role of adjuvants, induction and expansion of adaptive immune response, prime and boost strategies, success of DNA vaccines in cancer and infectious diseases, comparison of DNA vaccines to other vaccine modalities. We also invite the representatives of R&D companies and state agencies involved in the development, production and distribution of vaccines to discuss the business models for DNA vaccines, public perception of the vaccines and their perspectives for human and veterinarian use. Each thematic block will open with an introductory lecture introducing the basics and the main achievements in the given area. In the end of the introductory key-note lecture, the lectors share their views on the DNA vaccines and their pros and cons connected to the area covered. We encourage the spread of the information about the conference to the PhD and master students affiliation in your institute - we plan to give a lot of time to short presentations of young researchers performing vaccine-related research.

	Name	Added
For questions or suggestions, please contact the organizers.
	Belikov	Jan 25, 2017
	Belikova	Jan 25, 2017
	Chubarev	Jan 25, 2017
	Dovbenko	Jan 25, 2017
	Dzmitruk and Shcharbin	Jan 25, 2017
	Isaguliants	Jan 25, 2017
	Jansons	Jan 25, 2017
	Joseph	Jan 25, 2017
	Kalis	Jan 25, 2017
	Kalnina	Jan 25, 2017
	Karpenko	Jan 25, 2017
	Kozlov	Jan 25, 2017
	Lukashev	Jan 25, 2017
	Mezale	Jan 25, 2017
	Ostlund Farrants	Jan 25, 2017
	Pankova	Jan 25, 2017
	Podswadt	Jan 25, 2017
	Prostova	Jan 25, 2017
	Reche	Jan 25, 2017
	Rhee_Adjuvants	Jan 25, 2017
	Rhee	Jan 25, 2017
	Shneider Cancer Vaccine	Jan 25, 2017
	Shneider Adjuvants	Jan 25, 2017
	Sominskaya	Jan 25, 2017
	Ustinova	Jan 25, 2017
	Westerberg	Jan 25, 2017
	Zamyatnin	Jan 25, 2017
	Zusinate	Jan 25, 2017